Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1994
11/10/1994CA2160909A1 Cell-targeted lytic pore-forming agents
11/10/1994CA2160703A1 Method of separating glycosylated and non-glycosylated proteins
11/10/1994CA2159716A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994CA2159508A1 Method of enhancing thrombolysis
11/10/1994CA2159323A1 Dna segment comprising gene encoding insecticidal protein
11/10/1994CA2136734A1 Purification method for hydrophobic polypeptide
11/09/1994EP0623679A1 Targeted multifunctional proteins
11/09/1994EP0623676A1 Metalloproteinase inhibitor
11/09/1994EP0623674A1 Interleukin-1 receptors
11/09/1994EP0623628A1 Muscular dystrophy gene products, antibodies thereto and methods for immunodiagnosis of muscular dystrophy
11/09/1994EP0623606A2 Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
11/09/1994EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors
11/09/1994EP0623352A2 Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumorselective therapy
11/09/1994EP0623216A1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS
11/09/1994EP0623215A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
11/09/1994EP0623173A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1
11/09/1994EP0623172A1 Marek's disease virus recombinant poxvirus vaccine
11/09/1994EP0623170A1 Vaccines based on streptokinase
11/09/1994EP0623169A1 Hepatitis e virus vaccine and method
11/09/1994EP0623168A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
11/09/1994EP0623147A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus
11/09/1994EP0623146A1 COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FUNCTION
11/09/1994EP0623144A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
11/09/1994EP0623142A1 Mammalian adipogenic factors
11/09/1994EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/09/1994EP0477217B1 Stabilized, potent grf analogs
11/09/1994EP0460217B1 cDNA OF ORSV GENE
11/09/1994EP0420894B1 Large scale method for purification of high purity heparinase
11/09/1994EP0375718B1 Process for the production of aprotinin and aprotinin homologues in yeast
11/09/1994EP0341287B1 Diagnostic methods and systems for quantifying apo ai
11/09/1994EP0305500B1 Process for the purification of recombinant polypeptides
11/09/1994EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins
11/09/1994CN1094642A Therapeutic combination
11/09/1994CN1094640A Urease-based vaccine against helicobacter infection
11/09/1994CN1094609A Anticaries compositions
11/09/1994CN1026497C Insect-resistant plants
11/08/1994US5362865 Enhanced expression in plants using non-translated leader sequences
11/08/1994US5362864 Trans-activating factor-1
11/08/1994US5362857 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography
11/08/1994US5362856 Monooxygenase-like activity of heme proteins
11/08/1994US5362855 Imidoester cross-linked hemoglobin compositions
11/08/1994US5362854 Complexes
11/08/1994US5362853 Polypeptide derivatives of human granulocyte colony stimulating factor
11/08/1994US5362852 Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
11/08/1994US5362716 Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
11/08/1994US5362644 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, method for preparing them and also their applications
11/08/1994US5362641 Hydrolytic enzymes
11/08/1994US5362631 Capable of producing granulocyte/macrophage-colony simulating factor
11/08/1994US5362625 Methods and compositions for enzyme complementation assays using the omega region of β-galactosidase
11/08/1994US5362623 Sequence specific DNA binding by p53
11/08/1994US5362490 Human myelomonocyte interferon-gamma, and process for preparation and use thereof
11/08/1994US5362489 Lymphocytes
11/08/1994CA2123055A1 Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors
11/08/1994CA1332998C Prostate-derived growth factor
11/08/1994CA1332943C Process for preparing perhydrothiazepine derivatives
11/03/1994DE4342132C1 Process for the preparation of virus-inactivated vitamin K-dependent plasma components, and protein C and protein S-containing compositions by membrane chromatography
11/03/1994DE4314260A1 Peptides for the treatment of hypoglycaemia, process for the preparation thereof and the use thereof
11/03/1994DE4313933A1 Functional receptor expression in Dictyostelium discoideum
11/02/1994EP0622461A2 Preparation of yellow mosaic disease-resistant barley
11/02/1994EP0622460A2 Plasmid and escherichia coli transformed with it
11/02/1994EP0622459A1 Fused proteins for preparing vasoactive intestinal polypeptide analogs, method of preparing same and recombinant plasmids and transformant microorganisms
11/02/1994EP0622458A2 Adrenomedullin
11/02/1994EP0622456A1 Prokaryotic and eukaryotic vectors producing polypeptides containing epitopes of PDGF B
11/02/1994EP0622377A2 Amphotropic virus receptor
11/02/1994EP0622376A1 Amorphous monospheric forms of insulin derivatives
11/02/1994EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use
11/02/1994EP0622084A1 Antibody-drug conjugates
11/02/1994EP0622081A2 Epitopic regions of phneumococcal surface protein A
11/02/1994EP0622080A2 Gelatinase A inhibitor
11/02/1994EP0621902A1 Dna structure-specific recognition protein and uses therefor
11/02/1994EP0621901A1 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path
11/02/1994EP0621899A1 Expression signal-peptide-free staphylokinases.
11/02/1994EP0621898A1 Chimeric immunogens
11/02/1994EP0621893A1 Feline leukemia virus vaccines
11/02/1994EP0621875A1 Fibrinogen binding protein
11/02/1994EP0621874A1 Somatostatin receptors
11/02/1994EP0621873A1 A novel human kunitz-type protease inhibitor and variants thereof
11/02/1994EP0621872A1 A human kunitz-type protease inhibitor variant
11/02/1994EP0621868A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
11/02/1994EP0621790A1 Attenuated, live vaccine for delaware strain ibdv
11/02/1994EP0621789A1 Pharmaceutical pentapeptide compositions and methods of use thereof
11/02/1994EP0621788A1 Hemoregulatory peptides
11/02/1994EP0621780A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
11/02/1994EP0589961A4 Assay systems for neurotrophin activity.
11/02/1994EP0587719A4 DETECTION OF COLLAGEN DEGRADATION -i(IN VIVO).
11/02/1994EP0584283A4 Osteoinductive protein mixtures and purification processes.
11/02/1994EP0578784A4 Odorant receptors ans uses thereof.
11/02/1994EP0442961B1 Hybrid procoagulant proteins
11/02/1994EP0398961B1 Polypeptide compounds having growth hormone releasing activity
11/02/1994EP0382736B1 Receptor membranes
11/02/1994EP0377659B1 Follistatin and method of purifying same
11/02/1994EP0316378B1 Expression vector for adjustable expression of exogenous genes in prokaryotes
11/02/1994CN1094446A ECK receptor ligands
11/02/1994CN1094445A Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/02/1994CN1094411A Thymosin alpha-1 derivatives
11/02/1994CA2122556A1 Dna fragment, vector containing the dna fragment, transformant transformed with the vector and process for producing protein using the vector
11/01/1994US5360896 Glycosylated FGF
11/01/1994US5360894 C/EBP2 gene and recombinant C/EBP2
11/01/1994US5360893 DNA sequences encoding proteins used to elicit and detect programmed cell death
11/01/1994US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells